Trials / Completed
CompletedNCT00211458
Treatment of Age-Related Macular Degeneration With Anecortave Acetate
Treatment of Age-Related Macular Degeneration With Open-label Anecortave Acetate Sterile Suspension (15mg) Following Failed Treatment With Photodynamic Therapy With Visudyne
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- —
- Sponsor
- Manhattan Eye, Ear & Throat Hospital · Academic / Other
- Sex
- All
- Age
- 50 Years
- Healthy volunteers
- —
Summary
The purpose of this study is to provide compassionate use of anecortave acetate sterile suspension of 15 mg for a series of five patients as a means to control classic neovascularization following failure of treatment with photodynamic therapy using Visudyne.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Anecortave Acetate Sterile Suspension (15 mg) |
Timeline
- Start date
- 2005-09-01
- Primary completion
- 2007-09-01
- Completion
- 2007-09-01
- First posted
- 2005-09-21
- Last updated
- 2012-10-25
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00211458. Inclusion in this directory is not an endorsement.